The partnership will support MRI-guided delivery of investigational gene therapy EPY201 in first-in-human trials targeting focal refractory epilepsy, where precision administration is "key to efficacy and safety"
Systech International has launched TraceIQ, a new traceability platform combining pharmaceutical compliance capabilities with AI-assisted analytics to help manufacturers...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.